Literature DB >> 457839

Parathyroid function and vitamin D metabolism during human growth hormone replacement.

J M Gertner, R L Horst, A E Broadus, H Rasmussen, M Genel.   

Abstract

Changes in calcium and phosphorus metabolism were studied in nine children with GH deficiency before and during human GH replacement therapy. Parathyroid function and serum concentrations of physiologically important vitamin D metabolites were examined to determine their relationship to changes in mineral metabolism. By comparison with pretreatment values, the GH-treated children showed significant increases in growth rate and renal tubular phosphate reabsorption and a significant decrease in urinary calcium excretion after a standardized oral load. There was no significant change in serum concentrations of parathyroid hormone, 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, or 24,25-dihydroxyvitamin D or in nephrogenous cAMP excretion. Although GH has been proposed as a regulator of vitamin D metabolism, the present study demonstrates that the anabolic changes in calcium and phosphorus metabolism accompanying GH therapy are not mediated via changes in parathyroid hormone or vitamin D status.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457839     DOI: 10.1210/jcem-49-2-185

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Vitamin D and the kidney.

Authors:  Rajiv Kumar; Peter J Tebben; James R Thompson
Journal:  Arch Biochem Biophys       Date:  2012-03-15       Impact factor: 4.013

2.  Control of plasma 1,25-(OH)2-vitamin D concentrations by calcium and phosphorus in the rat: effects of hypophysectomy.

Authors:  R W Gray
Journal:  Calcif Tissue Int       Date:  1981       Impact factor: 4.333

3.  Bone mineral homeostasis, bone growth, and mineralisation during years of pubertal growth: a unifying concept.

Authors:  S Krabbe; I Transbøl; C Christiansen
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

4.  Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children.

Authors:  P H Stern; A B Taylor; N H Bell; S Epstein
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

Review 5.  Renal effects of growth hormone. II. Electrolyte homeostasis and body composition.

Authors:  G D Ogle; A R Rosenberg; G Kainer
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

Review 6.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

7.  Effects of growth hormone therapy and malnutrition on the growth of rats with renal failure.

Authors:  D R Powell; R G Rosenfeld; R L Hintz
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

8.  Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.

Authors:  P W Lambert; B W Hollis; N H Bell; S Epstein
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

9.  Serum vitamin D metabolites do not change in response to intravenous injection of thyrotropin releasing hormone (TRH) and growth hormone releasing factor (GHRF 1-44) in children.

Authors:  R Rosskamp; S Issa; W Burmeister
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

Review 10.  Vitamin D and growth hormone in children: a review of the current scientific knowledge.

Authors:  Susanna Esposito; Alberto Leonardi; Lucia Lanciotti; Marta Cofini; Giulia Muzi; Laura Penta
Journal:  J Transl Med       Date:  2019-03-18       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.